Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021

BACKGROUND: During the first half of 2021, we observed high vaccine effectiveness (VE) against SARS-CoV2-infection. The replacement of the alpha-‘variant of concern’ (VOC) by the delta-VOC and uncertainty about the time course of immunity called for a re-assessment. METHODS: We estimated VE against...

Descripción completa

Detalles Bibliográficos
Autores principales: Braeye, Toon, Catteau, Lucy, Brondeel, Ruben, van Loenhout, Joris A.F., Proesmans, Kristiaan, Cornelissen, Laura, Van Oyen, Herman, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Djiena, Achille, Mahieu, Romain, Hammami, Naima, Van Cauteren, Dieter, Wyndham-Thomas, Chloé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001203/
https://www.ncbi.nlm.nih.gov/pubmed/35459558
http://dx.doi.org/10.1016/j.vaccine.2022.04.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001203/
https://www.ncbi.nlm.nih.gov/pubmed/35459558
http://dx.doi.org/10.1016/j.vaccine.2022.04.025

Ejemplares similares